1. ScholarBank@NUS

Peter Edward Lobie

rp06527

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Peter Edward Lobie
(not current staff)
Variants
Lobie, P.E.
 
Main Affiliation
 
Faculty
 
Email
phcpel@nus.edu.sg
 
Other emails
 

Publications

Results 41-60 of 67 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
4115-Nov-2012Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cellsQian, P.; Banerjee, A.; Wu, Z.-S.; Zhang, X.; Wang, H.; Pandey, V.; Zhang, W.-J.; Lv, X.-F.; Tan, S.; Lobie, P.E. ; Zhu, T.
220-Aug-2016Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast CarcinomaLoo, Ser Yue ; Hirpara, Jayshree L ; Pandey, Vijay ; Tan, Tuan Zea ; Yap, Celestial T ; Lobie, Peter E ; Thiery, Jean Paul ; Goh, Boon Cher ; Pervaiz, Shazib ; Clement, Marie-Veronique ; Kumar, Alan Prem 
32-Aug-2012MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expressionKong, X.; Li, G.; Yuan, Y.; He, Y.; Wu, X.; Zhang, W.; Wu, Z.; Chen, T.; Wu, W.; Lobie, P.E. ; Zhu, T.
421-Jul-2011MiR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathwayTan, S.; Li, R.; Ding, K.; Lobie, P.E. ; Zhu, T.
52017MiR-23a modulates X-linked inhibitor of apoptosis-mediated autophagy in human luminal breast cancer cell linesChen, P; He, Y.-H; Huang, X; Tao, S.-Q; Wang, X.-N; Yan, H; Ding, K.-S; Lobie, P.E ; Wu, W.-Y; Wu, Z.-S
625-Nov-1997Mode of the autocrine/paracrine mechanism of growth hormone actionLiu, N. ; Mertani, H.C. ; Norstedt, G.; Törnell, J.; Lobie, P.E. 
72018N-substituted pyrido-1,4-Oxazin-3-ones induce apoptosis of hepatocellular carcinoma cells by targeting NF-?B signaling pathwayMohan, C.D; Bharathkumar, H; Dukanya, Department of Studies in Organic Chemistry, University of Mysore, Mysore, India; Rangappa, S; Shanmugam, M.K ; Chinnathambi, A; Alharbi, S.A; Alahmadi, T.A; Bhattacharjee, A; Lobie, P.E ; Deivasigamani, A; Hui, K.M; Sethi, G ; Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Bangalore, India, Department of Studies in Organic Chemistry, University of Mysore, Mysore, India; Rangappa, K.S; Kumar, A.P 
81-Jul-2003Nuclear translocation and retention of growth hormoneMertani, H.C.; Raccurt, M.; Abbate, A.; Kindblom, J.; Törnell, J.; Billestrup, N.; Usson, Y.; Morel, G.; Lobie, P.E. 
91-Jan-2005Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormoneZhu, T. ; Emerald, B.S.; Zhang, X.; Lee, K.-O.; Gluckman, P.D.; Mertani, H.C.; Lobie, P.E. 
102019Pharmacological inhibition of TFF3 enhances sensitivity of CMS4 colorectal carcinoma to 5-fluorouracil through inhibition of p44/42 MAPKChen, R.-M. ; Chiou, Y.-S.; Chong, Q.-Y. ; Poh, H.-M.; Tan, T.-Z. ; Zhang, M.-Y.; Ma, L.; Zhu, T.; Pandey, V.; Salundi, B.; Prem Kumar, A. ; Lobie, P.E. 
1119-Oct-2004Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormoneMukhina, S.; Mertani, H.C.; Guo, K.; Lee, K.-O. ; Gluckman, P.D.; Lobie, P.E. 
12Nov-2017PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.Chen, Luxi ; Yuan, Yi; Kar, Shreya; Kanchi, Madhu M ; Arora, Suruchi; Kim, Ji E; Koh, Pei F ; Yousef, Einas; Samy, Ramar P ; Shanmugam, Muthu K ; Tuan Z ; Shin, Sung W; Arfuso, Frank; Shen, Han M ; Yang, Henry; Goh, Boon C ; Park, Joo I; Gaboury, Louis; Lobie, Peter E ; Sethi, Gautam ; Lim, Lina HK ; Kumar, Alan P 
13Jul-2011Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in hepatocellular carcinomaWu, W.-Y.; Li, J.; Wu, Z.-S.; Zhang, C.-L.; Meng, X.-L.; Lobie, P.E. 
1426-Jan-2013Prognostic significance of the expression of GFRα1, GFRα3 and Syndecan-3, Proteins binding ARTEMIN, In mammary carcinomaWu, Z.-S.; Pandey, V.; Wu, W.-Y.; Ye, S.; Zhu, T.; Lobie, P.E. 
152017Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinomaChong, Q.-Y ; You, M.-L ; Pandey, V ; Banerjee, A ; Chen, Y.-J; Poh, H.-M; Zhang, M; Ma, L; Zhu, T; Basappa, Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, Central College Campus, Bangalore, India; Liu, L; Lobie, P.E 
161-Dec-2013SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapyJung, Y.; Abdel-Fatah, T.M.A.; Chan, S.Y.T.; Nolan, C.C.; Green, A.R.; Ellis, I.O.; Li, L.; Huang, B.; Lu, J.; Xu, B.; Chen, L.; Ma, R.Z.; Zhang, M.; Wang, J.; Wu, Z.; Zhu, T.; Perry, J.K.; Lobie, P.E. ; Liu, D.-X.
1718-Jul-2003Src-CrkII-C3G-dependent activation of Rap1 switches growth hormone-stimulated p44/42 MAP kinase and JNK/SAPK activitiesLing, L.; Zhu, T.; Lobie, P.E. 
18Sep-2010STAT3α is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormoneTang, J.-Z.; Kong, X.-J.; Banerjee, A.; Muniraj, N.; Pandey, V.; Steiner, M.; Perry, J.K.; Zhu, T.; Liu, D.-X.; Lobie, P.E. 
13921-Feb-2003The growth hormone-binding protein is a location-dependent cytokine receptor transcriptional enhancerGraichen, R.; Sandstedt, J.; Goh, E.L.K.; Isaksson, O.G.P.; Törnell, J.; Lobie, P.E. 
14021-Feb-2012The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathwayJin, K.; Kong, X.; Shah, T.; Penet, M.-F.; Wildes, F.; Sgroi, D.C.; Ma, X.-J.; Huang, Y.; Kallioniemi, A.; Landberg, G.; Bieche, I.; Wu, X.; Lobie, P.E. ; Davidson, N.E.; Bhujwalla, Z.M.; Zhu, T.; Sukumar, S.